Institute of Clinical Oncology (შპს კლინიკური ონკოლოგიის ინსტიტუტი) — Georgia Financials

Georgia Financials

panel 2026-09-21Ask

Institute of Clinical Oncology (შპს კლინიკური ონკოლოგიის ინსტიტუტი) — Georgia Financials

separate · GEL, thousands

Line item	2018	2019	2020	2021	2022	2023	2024	CAGR
Total Revenue	7,480	6,764	6,096	6,853	7,016	8,988	12,787	+9.3%
Total COGS	560	582	694	866	652	996	1,305	+15.1%
Gross Profit	6,919	6,182	5,403	5,987	6,365	7,992	11,482	+8.8%
Gross Margin	92.5%	91.4%	88.6%	87.4%	90.7%	88.9%	89.8%
Other Operating Income	0	28	1,061	1,280	1,553	1,907	2,875	nmf
	4,364	4,382	4,457	4,272	5,469	7,320	10,186	+15.2%
EBITDA	2,555	1,828	2,006	2,996	2,449	2,578	4,171	+8.5%
EBITDA Margin	34.2%	27.0%	32.9%	43.7%	34.9%	28.7%	32.6%
Total D&A	700	683	0	628	583	692	1,103	+7.9%
EBIT / Operating Income	1,855	1,145	2,006	2,367	1,866	1,886	3,068	+8.7%
Total Interest Income	16	4	0	0	0	18	0	+2.5%
Total Interest Expense	62	40	15	43	95	166	1,025	+59.7%
	149	740	241	252	233	269	344	nmf
Profit Before Tax	1,958	1,850	2,232	2,073	1,538	2,007	1,699	-2.3%
Total Income Tax	0	0	0	0	0	0	0
Net Profit / (Loss)	1,956	1,850	2,232	2,073	1,538	2,007	1,699	-2.3%
Net Margin	26.1%	27.3%	36.6%	30.2%	21.9%	22.3%	13.3%